As of January 22, 2025, Inventiva (IVA) has a market cap of $0.21 billion USD. According to our data, Inventiva is ranked No.7069 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.21 B |
87.08%
|
Dec 31, 2024 | $0.11 B |
-52.61%
|
Dec 29, 2023 | $0.24 B |
1.26%
|
Dec 30, 2022 | $0.23 B |
-67.35%
|
Dec 31, 2021 | $0.72 B |
-5.79%
|
Dec 31, 2020 | $0.76 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Madrigal Pharmaceuticals
MDGL
|
$6.99 B |
0.000 M
|
USA
|
Genfit
GNFT
|
$0.18 B |
-0.000 M
|
France
|
Galmed Pharmaceuticals
GLMD
|
$4.85 M |
0.000 M
|
Israel
|
Viking Therapeutics
VKTX
|
$3.89 B |
0.000 M
|
USA
|
Akero Therapeutics
AKRO
|
$1.75 B |
-0.033 B
|
USA
|
89bio
ETNB
|
$0.78 B |
0.000 M
|
USA
|
Hepion Pharmaceuticals
HEPA
|
$0.89 M |
0.000 M
|
USA
|
Terns Pharmaceuticals
TERN
|
$0.39 B |
-0.000 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Market Cap | = | IVA Stock Price | * | IVA Shares Outstanding |
= | $2.17 | * | 52.36 M | |
= | $0.21 B |